Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1: Double Blind Treatment	STARTED	Sequence 1: Oxytocin-oxytocin	12
Period 1: Double Blind Treatment	STARTED	jSequence 2: Placebo-oxytocin	13
Period 1: Double Blind Treatment	COMPLETED	Sequence 1: Oxytocin-oxytocin	11
Period 1: Double Blind Treatment	COMPLETED	jSequence 2: Placebo-oxytocin	13
Period 1: Double Blind Treatment	NOT COMPLETED	Sequence 1: Oxytocin-oxytocin	1
Period 1: Double Blind Treatment	NOT COMPLETED	jSequence 2: Placebo-oxytocin	0
Period 2: Open Label Treatment	STARTED	Sequence 1: Oxytocin-oxytocin	11
Period 2: Open Label Treatment	STARTED	jSequence 2: Placebo-oxytocin	13
Period 2: Open Label Treatment	COMPLETED	Sequence 1: Oxytocin-oxytocin	11
Period 2: Open Label Treatment	COMPLETED	jSequence 2: Placebo-oxytocin	11
Period 2: Open Label Treatment	NOT COMPLETED	Sequence 1: Oxytocin-oxytocin	0
Period 2: Open Label Treatment	NOT COMPLETED	jSequence 2: Placebo-oxytocin	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01308749/flow